此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of Patients With Burn Injuries

2026年8月15日 更新者:Ain Shams University

Measurement of Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for 30-day Mortality of Patients With Burn Injuries

The aim of this study is to evaluate the prognostic utility of the red cell distribution width/albumin ratio (RAR), measured within 24 hours of hospital admission, in predicting 30-day mortality among patients with burn injuries.

研究概览

地位

招聘中

条件

详细说明

The aim of this study is to evaluate the prognostic utility of the red cell distribution width/albumin ratio (RAR), measured within 24 hours of hospital admission, in predicting 30-day mortality among patients with burn injuries.

Patients presenting with acute thermal injuries will be screened based on inclusion/exclusion criteria.

After consent, patients' characteristics (age, sex, weight), clinical parameters (total burn surface area, Abbreviated Burn Severity Index), and comorbidities will be recorded.

  1. Emergency Department (ED) management (Arrival and Initial Stabilization)

    • Primary survey (ATLS principles): Immediate stabilization of Airway, Breathing, Circulation, Disability, Exposure (ABCDE).

    • Urinary catheter insertion to monitor urine output for proper resuscitation.
    • TBSA will be estimated using the Rule of Nines
    • All patients will be treated during the first 24 hours after burn injury guided by the Parkland Formula.
  2. In-Hospital Resuscitation (0-72 h)

    • Hemodynamic monitoring: ECG, pulse oximetry, respiratory rate, temperature, non-invasive blood pressure, arterial line if unstable, and central venous pressure.

    • Transition to Day 2 (24-48 h post-burn): Continue Lactated Ringer's and consider colloid therapy (5% albumin or plasma) after 24 h to maintain oncotic pressure and reduce crystalloid load.

    • Fluid adjustments according to urine output, mean arterial pressure with target MAP (≥65 mmHg), lactate clearance, and base deficit.

    Laboratory and calculation:

    On admission to ED, an arterial blood gas (ABG) sample will be collected to calculate base deficit (BD) and lactate level.

    Simultaneously, venous blood will be drawn for C-reactive protein (CRP) and serum albumin, CBC, serum urea, creatinine, AST, ALT, and electrolytes (Na+, K+, Mg+) estimation.

    Red Cell Distribution Width/Albumin will be calculated as:

    ((RDW (Standard Deviation of Red Blood Cell Volume / Mean Corpuscular Volume) × 100%.) / albumin (g/L)) from admission labs.

    Serial: Lactate/Base Deficit at 6 hr, 12 hr, 24 hr as a monitor for proper resuscitation Calculation of Severity Scores

    • R-Baux score: Age (years) + %TBSA + (17 × inhalation injury [yes=1, no=0])

    • Abbreviated Burn Severity Index (ABSI): The ABSI includes five parameters: sex, age category, %TBSA, presence of full-thickness burns, and inhalation injury. Each parameter is assigned weighted points, and the total ABSI score is associated with graded survival probabilities.

    Both scores will be calculated on admission and compared with admission (RDW/albumin) ratio to assess relative and incremental predictive value for 30-day mortality.

    Supportive care:

    • Early enteral nutrition, proper multimodal analgesia (paracetamol 1gm/8hr, nalbuphine 0.1mg/kg if VAS score>4), IV proton pump inhibitor to guard against curling ulcer, prophylactic anticoagulation to guard against DVT.
    • Vasopressors (norepinephrine) only after adequate fluid resuscitation guided by UOP, lactate and BD if MAP below 65 mmHg.

      3 - Post-Resuscitation and Definitive Management Protocol (After 72 h) Hemodynamic stabilization (post-resuscitation phase) Transition from resuscitation fluids to maintenance fluids. Avoid "fluid creep" (excess positive balance leading to pulmonary edema, abdominal compartment). → cautious use of diuretics to mobilize edema.

    Maintain: MAP ≥65 mmHg, urine output ≥0.5 mL/kg/h. Ongoing ventilatory support if required; lung-protective strategy for ARDS. Weaning as early as possible.

    Infection prevention and sepsis monitoring

    • Daily wound assessment for signs of infection, weekly or targeted wound/blood cultures and antibiotics only if infection is suspected/proven (not prophylactic).

    Wound care and surgical management

    • Regular dressing, use of negative-pressure wound therapy when indicated.

    • Early excision and grafting after 72 hr. Pain and sedation control
    • Multimodal analgesia, pre-procedure analgesia for dressing/grafting and long-term psychological and pain management.

    Rehabilitation and functional recovery • Early physiotherapy, occupational therapy for daily living skills and psychosocial support for patient and family.

    Criteria for transfer to ward • Hemodynamically stable, off vasopressors.

    • Stable oxygenation without advanced ventilatory support.

    • Tolerating enteral feeding.

    • Wounds coverage completed or adequately covered with new TBSA% below 20%.

    • Patients will be followed for 30 days at Ain Shams University burn unit. Measured outcomes

    Primary outcome:

    To determine the correlation between Red Cell Distribution Width/Albumin on admission and 30-day hospital mortality in burn patients.

    Secondary outcomes:

    To determine the correlation between Red Cell Distribution Width/Albumin with:

    • ICU length of stay
    • Hospital length of stay
    • Requirements of inotropes or vasopressors
    • Duration of mechanical ventilation
    • To compare Red Cell Distribution Width/albumin ratio with R-Baux score as a predictor of mortality in burn patients.

研究类型

观察性的

注册 (估计的)

30

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

  • 姓名:Sara H Saleh, MD
  • 电话号码:+201001584305

学习地点

    • Cairo Governorate
      • Cairo、Cairo Governorate、埃及、11111
        • 招聘中
        • Ain Shams University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

取样方法

概率样本

研究人群

Patients presenting with acute thermal injuries will be screened based on inclusion/exclusion criteria.

After consent, Patients' characteristics (age, sex, weight), clinical parameters (Total burn surface area, Abbreviated burn severity index), and comorbidities will be recorded.

描述

Inclusion Criteria:

  • Age > 18 years.
  • Both sexes.
  • Patients with burn injuries (%TBSA >20%).
  • Availability of complete laboratory data (RDW, albumin) on admission.
  • Admission to ICU within 24 hours of burn injury.

Exclusion Criteria:

  • Age <18 years.
  • Patients with chronic hematologic disease.
  • Pre-existing liver disease.
  • Nephrotic syndrome.
  • patients on chemotherapy.
  • Patients with incomplete or missing lab records.
  • Pregnant females.
  • Patient or guardian refusal.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
• Patients with burn injuries (%TBSA >20%)
each patient will be followed for 30 days for mortality prediction

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
mortality in burn patients
大体时间:30 days
To determine the correlation between Red Cell Distribution Width/Albumin on admission and 30 days hospital mortality in burn patients.
30 days

次要结果测量

结果测量
措施说明
大体时间
ICU length of stay
大体时间:30 days
To determine the correlation between Red Cell Distribution Width/Albumin with o ICU length of stay
30 days
Requirements of inotropes or vasopressors
大体时间:30 days

To determine the correlation between Red Cell Distribution Width/Albumin with

o Requirements of inotropes or vasopressors

30 days
Duration of mechanical ventilation
大体时间:30 days

To determine the correlation between Red Cell Distribution Width/Albumin with

o Duration of mechanical ventilation

30 days
To compare RDW/albumin ratio with Revised Baux score as a predictor of mortality in burn patient.
大体时间:30 days
Revised Baux score = (percent body surface burned) + (patient's age) + 17 (if inhalational injury is present) A higher Revised Baux score generally indicates a higher risk of mortality, with scores over 140 unsurvivable .
30 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Adel M Fahmy Shenouda, MD、Department of Anesthesia, Intensive care and pain management, Faculty of Medicine, Ain Shams University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年8月1日

初级完成 (估计的)

2027年2月1日

研究完成 (估计的)

2027年4月1日

研究注册日期

首次提交

2026年8月8日

首先提交符合 QC 标准的

2026年8月8日

首次发布 (实际的)

2026年8月12日

研究记录更新

最后更新发布 (实际的)

2026年8月18日

上次提交的符合 QC 标准的更新

2026年8月15日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • FMASU MD361/2025

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

De-identified individual participant data underlying the study results will be made available upon reasonable request from qualified researchers

IPD 共享时间框架

Within 6:12 months

IPD 共享访问标准

Access will be granted to researchers who submit a methodologically sound proposal to the principal investigator. Requests should be directed to g19-29502090100101@med.asu.edu.eg

IPD 共享支持信息类型

  • 研究方案

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅